M&A

Is Merck's Planned Acquisition of Acceleron in Trouble?
Motley Fool
Sat, 11/13/21 - 09:55 pm
Merck
Acceleron
M&A
Organon makes another women’s health move with deal for endometriosis-focused Forendo
MedCity News
Thu, 11/11/21 - 10:58 am
Organon
Forendo Pharma
Merck
endometriosis
M&A
Women's Health
Coloplast acquires laryngectomy device maker Atos Medical in $2.5B takeover
Medtech Dive
Wed, 11/10/21 - 09:34 pm
devices
Coloplast
M&A
Atos Medical
laryngectomy
After snapping up Parexel with Goldman Sachs, EQT doubles down on healthcare with Life Sciences Partners buyout
Fierce Biotech
Wed, 11/10/21 - 10:28 am
EQT
Parexel
Life Science Partners
M&A
Big Pharma Is Going Holiday Shopping. Who's Next?
Motley Fool
Wed, 11/10/21 - 10:13 am
Big Pharma
M&A
ChemoCentryx
Epizyme
Magenta Therapeutics
Philips builds on cardiac monitoring with Cardiologs acquisition
MedCity News
Mon, 11/8/21 - 11:12 pm
Philips
Cardiologs
M&A
cardiac monitoring
remote patient monitoring
Swiss socialists say government should buy Sandoz
Pharmaforum
Mon, 11/8/21 - 10:38 am
Switzerland
Novartis
Sandoz
M&A
generics
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
Motley Fool
Sun, 11/7/21 - 10:55 pm
Bristol Myers Squibb
Aurinia Pharmaceuticals
M&A
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Novartis
M&A
Roche
Sandoz
Aurinia Pharmaceuticals
Alnylam
Exelixis
Incyte
Eisai
Genmab
2 Biotech Companies That Might Be on Pfizer's Radar Right Now
Motley Fool
Thu, 11/4/21 - 10:37 am
Pfizer
M&A
Adaptimmune Therapeutics
Affimed
Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals
Motley Fool
Wed, 11/3/21 - 10:39 am
Bristol Myers Squibb
Aurinia Pharmaceuticals
M&A
Acquisition Rumors Continue to Circulate Around Aurinia as GSK Denies Interest
BioSpace
Mon, 11/1/21 - 11:21 pm
GSK
Aurinia Pharmaceuticals
M&A
Merck Delays Acceleron Deal Amidst Continuing Stakeholder Criticism
BioSpace
Mon, 11/1/21 - 11:19 pm
Merck
Accerleron
M&A
FTC
DOJ
Takeda to buy GammaDelta to accelerate allogeneic cell therapies development
Pharmaceutical Business Review
Thu, 10/28/21 - 10:37 am
Takeda
GammaDelta Therapeutics
M&A
allogeneic cells
solid tumors
ElevateBio cuts a deal for Life Edit, adding genome engineering tech to support gene therapy pipeline
Fierce Biotech
Wed, 10/27/21 - 11:05 am
Elevate Bio
Life Edit Therapeutics
gene therapy
genome editing
M&A
2 Biotech Stocks That Could Go Parabolic This Week
Motley Fool
Mon, 10/25/21 - 10:57 am
biotech
biotech stocks
Aurinia Pharmaceuticals
M&A
Ocugen
Covaxin
vaccines
COVID-19
Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout
Fierce Pharma
Sun, 10/24/21 - 10:40 pm
Bristol Myers Squibb
Acceleron
M&A
Aurinia Pharmaceuticals
23andMe Jumps into Telehealth with New M&A
Medical Devices and Diagnostics Industry
Sun, 10/24/21 - 10:34 pm
23andMe
diagnostics
M&A
Lemonaid Health
telehealth
Bristol Myers pledges to sell its Acceleron shares as activist investors circle Merck's $11.5B buyout — report
Endpoints
Thu, 10/21/21 - 09:31 am
Merck
Acceleron
M&A
Bristol Myers Squibb
Why Supernus' Acquisition of Adamas Is a Smart Move
Motley Fool
Thu, 10/21/21 - 09:30 am
Supernus
Adamas Pharmaceuticals
M&A
Parkinson's Disease

Pages